Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-15

Clinical Trial Update: Evaluation of Patiromer in Heart Failure Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating patiromer in patients with hyperkalemia and heart failure has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Patiromer (patiromer)

Snippet

Sponsor: Relypsa, Inc. | Conditions: Hyperkalemia, Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2015-12-15